Delivery Order SPE2DB22D3301-SPE2DB26FX3SU
Award Date 10/23/25
Potential Completion Date 11/14/25
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and was awarded on September 18, 2025. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. The performance location...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,360 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 8, 2025, and performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, demonstrating the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 12, 2025, with completion scheduled for October 3, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the company's facility at the same location in Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $7,080.84 with a firm fixed price structure. This non-competitive delivery order is expected to be completed by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply fulfillment under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $34,908.00 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract was competitively awarded on August 20, 2025, with a firm fixed price structure and an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.41 to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 mL vial (100 mL), with an ultimate completion date of October 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials valued at $6,092.18 with a completion date of November 10, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,040.44 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immunoglobulin vial. The contract was competitively awarded without set-aside designation and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a firm fixed price transaction for specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,327.20 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement needs,...